MarketBeat Instant News Alerts 2 hours agoEvolv Technologies (NASDAQ:EVLV) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPSMarketBeatEvolv Technologies (NASDAQ:EVLV - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Evolv Technologies had a negative return on equity of 33.53% and a negative net margin of 22.75%.The firm had revenue of $43.75 million for the quarter, compared to analysts' expectations of $41.80 million. NASDAQ:EVLVRead Evolv Technologies (NASDAQ:EVLV) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS2 hours agoElectra Battery Materials (NASDAQ:ELBM) Releases Earnings Results, Beats Expectations By $0.07 EPSMarketBeatElectra Battery Materials (NASDAQ:ELBM - Get Free Report) released its earnings results on Wednesday. The company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of ($0.02) by $0.07. NASDAQ:ELBMRead Electra Battery Materials (NASDAQ:ELBM) Releases Earnings Results, Beats Expectations By $0.07 EPS2 hours agoBrainsway (NASDAQ:BWAY) Posts Earnings Results, Misses Estimates By $0.03 EPSMarketBeatBrainsway (NASDAQ:BWAY - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03). The business had revenue of $17.11 million during the quarter, compared to analysts' expectations of $16.54 million. Brainsway had a net margin of 15.68% and a return on equity of 12.28%. NASDAQ:BWAYRead Brainsway (NASDAQ:BWAY) Posts Earnings Results, Misses Estimates By $0.03 EPS2 hours agoAnnexon (NASDAQ:ANNX) Issues Earnings Results, Misses Estimates By $0.05 EPSMarketBeatAnnexon (NASDAQ:ANNX - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.05). NASDAQ:ANNXRead Annexon (NASDAQ:ANNX) Issues Earnings Results, Misses Estimates By $0.05 EPS2 hours agoAltimmune (NASDAQ:ALT) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPSMarketBeatAltimmune (NASDAQ:ALT - Get Free Report) released its earnings results on Wednesday. The company reported ($0.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.14) by $0.02. Altimmune had a negative net margin of 214,860.98% and a negative return on equity of 42.57%. NASDAQ:ALTRead Altimmune (NASDAQ:ALT) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS2 hours agoAcumen Pharmaceuticals (NASDAQ:ABOS) Releases Quarterly Earnings Results, Misses Estimates By $0.09 EPSMarketBeatAcumen Pharmaceuticals (NASDAQ:ABOS - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.36) by ($0.09). NASDAQ:ABOSRead Acumen Pharmaceuticals (NASDAQ:ABOS) Releases Quarterly Earnings Results, Misses Estimates By $0.09 EPS Trending News1Bank of America Corp DE Purchases 7,079,903 Shares of NIO Inc. $NIO2Super Micro Computer, Inc. $SMCI Shares Bought by Quantinno Capital Management LP3Bank of New York Mellon Corp Acquires 221,957 Shares of SELLAS Life Sciences Group, Inc. $SLS4Brokers Issue Forecasts for Datavault AI FY2026 Earnings5Janus Henderson Group PLC Takes Position in Rezolve AI PLC $RZLV6California State Teachers Retirement System Acquires 488,883 Shares of Plug Power, Inc. $PLUG7Alphabet (NASDAQ:GOOGL) Stock Price Down 3.8% - Time to Sell?8SpaceX (NASDAQ:SPCX) Shares Up 4.2% Following Analyst Upgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoNeedham & Company LLC Issues Pessimistic Forecast for Radcom (NASDAQ:RDCM) Stock PriceMarketBeatNASDAQ:RDCMRead Needham & Company LLC Issues Pessimistic Forecast for Radcom (NASDAQ:RDCM) Stock Price2 hours agoRapport Therapeutics (NASDAQ:RAPP) Given New $66.00 Price Target at HC WainwrightMarketBeatNASDAQ:RAPPRead Rapport Therapeutics (NASDAQ:RAPP) Given New $66.00 Price Target at HC Wainwright2 hours agoBrainsway (NASDAQ:BWAY) Given New $20.00 Price Target at BTIG ResearchMarketBeatNASDAQ:BWAYRead Brainsway (NASDAQ:BWAY) Given New $20.00 Price Target at BTIG Research2 hours agoACV Auctions (NYSE:ACVA) Trading 9% Higher Following Analyst UpgradeMarketBeatNYSE:ACVARead ACV Auctions (NYSE:ACVA) Trading 9% Higher Following Analyst Upgrade2 hours agoPolyPid (NASDAQ:PYPD) Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPSMarketBeatNASDAQ:PYPDRead PolyPid (NASDAQ:PYPD) Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS2 hours agoRadcom (NASDAQ:RDCM) Issues Earnings ResultsMarketBeatNASDAQ:RDCMRead Radcom (NASDAQ:RDCM) Issues Earnings Results2 hours agoSpruce Biosciences (NASDAQ:SPRB) Issues Quarterly Earnings Results, Misses Estimates By $0.89 EPSMarketBeatNASDAQ:SPRBRead Spruce Biosciences (NASDAQ:SPRB) Issues Quarterly Earnings Results, Misses Estimates By $0.89 EPS2 hours agoTScan Therapeutics (NASDAQ:TCRX) Releases Earnings Results, Beats Expectations By $0.06 EPSMarketBeatNASDAQ:TCRXRead TScan Therapeutics (NASDAQ:TCRX) Releases Earnings Results, Beats Expectations By $0.06 EPS2 hours agoUnicycive Therapeutics (NASDAQ:UNCY) Announces Quarterly Earnings ResultsMarketBeatNASDAQ:UNCYRead Unicycive Therapeutics (NASDAQ:UNCY) Announces Quarterly Earnings Results2 hours agoVinci Compass Investments (NASDAQ:VINP) Releases Earnings Results, Misses Estimates By $0.02 EPSMarketBeatNASDAQ:VINPRead Vinci Compass Investments (NASDAQ:VINP) Releases Earnings Results, Misses Estimates By $0.02 EPS2 hours agoXilio Therapeutics (NASDAQ:XLO) Announces Earnings Results, Beats Estimates By $0.26 EPSMarketBeatNASDAQ:XLORead Xilio Therapeutics (NASDAQ:XLO) Announces Earnings Results, Beats Estimates By $0.26 EPS2 hours agoCLS (LON:CLI) Releases Earnings ResultsMarketBeatLON:CLIRead CLS (LON:CLI) Releases Earnings Results2 hours agoEvoke (LON:EVOK) Issues Quarterly Earnings ResultsMarketBeatLON:EVOKRead Evoke (LON:EVOK) Issues Quarterly Earnings Results2 hours agoGenuit Group (LON:GEN) Releases Quarterly Earnings ResultsMarketBeatLON:GENRead Genuit Group (LON:GEN) Releases Quarterly Earnings Results2 hours agoInsider Selling: CompX International (NYSE:CIX) Director Sells 1,500 SharesMarketBeatNYSE:CIXRead Insider Selling: CompX International (NYSE:CIX) Director Sells 1,500 Shares2 hours agoAtmos Energy (NYSE:ATO) Director Acquires $50,277.00 in StockMarketBeatNYSE:ATORead Atmos Energy (NYSE:ATO) Director Acquires $50,277.00 in Stock2 hours agoAlpha Tau Medical (NASDAQ:DRTS) CFO Sells $248,220.00 in StockMarketBeatNASDAQ:DRTSRead Alpha Tau Medical (NASDAQ:DRTS) CFO Sells $248,220.00 in Stock2 hours agoBradley Irwin Sells 4,300 Shares of Church & Dwight (NYSE:CHD) StockMarketBeatNYSE:CHDRead Bradley Irwin Sells 4,300 Shares of Church & Dwight (NYSE:CHD) Stock2 hours agoRiley Exploration Permian (NYSE:REPX) CEO Sells 12,500 Shares of StockMarketBeatNYSE:REPXRead Riley Exploration Permian (NYSE:REPX) CEO Sells 12,500 Shares of Stock2 hours agoH. B. Fuller (NYSE:FUL) VP Sells $593,355.66 in StockMarketBeatNYSE:FULRead H. B. Fuller (NYSE:FUL) VP Sells $593,355.66 in Stock2 hours agoTower Semiconductor (NASDAQ:TSEM) CEO Sells 77,309 Shares of StockMarketBeatNASDAQ:TSEMRead Tower Semiconductor (NASDAQ:TSEM) CEO Sells 77,309 Shares of Stock2 hours agoRussell Craig Ellwanger Sells 104,226 Shares of Tower Semiconductor (NASDAQ:TSEM) StockMarketBeatNASDAQ:TSEMRead Russell Craig Ellwanger Sells 104,226 Shares of Tower Semiconductor (NASDAQ:TSEM) Stock2 hours agoCandel Therapeutics Eyes 2026 Prostate Cancer Filing as Lung Study Ramps UpMarketBeatNASDAQ:CADLRead Candel Therapeutics Eyes 2026 Prostate Cancer Filing as Lung Study Ramps Up2 hours agoBorr Drilling Q2 Earnings Call HighlightsMarketBeatNYSE:BORRRead Borr Drilling Q2 Earnings Call Highlights Featured Articles and OffersSoundHound AI Sends a Loud Signal After Its Q2 Earnings BeatBy Thomas Hughes | August 10, 2026SpaceX pays a 10X launch penaltyFrom Freedom Financial (Ad)Bank of America Corp DE Purchases 7,079,903 Shares of NIO Inc. $NIOBy MarketBeat | August 9, 2026Quantum Earnings Week: Winners and Losers Are Finally EmergingBy Nathan Reiff | August 8, 20263 Stocks Whose Charts May Be Signaling the Next Big MoveBy Dan Schmidt | August 9, 2026America's nuclear chokehold is breakingFrom Monument Traders Alliance (Ad)Sandisk Just Delivered a Blowout Quarter—Here's Why the Stock Is FallingBy Sam Quirke | August 6, 2026SpaceX: Love the Company, But the Stock Is a Harder CallBy Thomas Hughes | August 5, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 400 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
